Abstract
Business ethics of innovation strives to give orientation in settings where new products, new markets, new environments are predominant. The provision of new products and solutions is inseparably intertwined with the consequences of their use. These can be manifold and in some cases an (unwanted) consequence might even preclude them from being used. A case in point is illustrated by an example from the pharmaceutical industry.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beauchamp TL, Bowie NE (2004) Ethical theory and business. Prentice Hall, Upper Saddle River, p 90
Crane A, Matten D (2004) Business Ethics. Oxford University Press, Oxford, p 45
De George RT (2005) Business ethics. Prentice Hall, Upper Saddle River
Eaton ML (2004) Ethics and the business of bioscience. Stanford University Press, Stanford
Velasquez MG (2002) Business Ethics. Concepts and Cases. Prentice Hall, Upper Saddle River, p 2
Author information
Authors and Affiliations
Corresponding author
Additional information
An earlier version of this paper appeared in the Newsletter No. 49, September 2004 of the Europäische Akademie GmbH, ISSN 1432–0150.
Rights and permissions
About this article
Cite this article
Hanekamp, G. Business Ethics of Innovation. Poiesis Prax 3, 310–314 (2005). https://doi.org/10.1007/s10202-005-0001-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10202-005-0001-4